This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Genethon. Active years: 2018-2021.
Company Filing History:
Years Active: 2018-2021
Title: Jérémy Rouillon: Innovator in Muscular Dystrophy Diagnosis
Introduction
Jérémy Rouillon is a notable inventor based in Corbeil-Essonnes, France. He has made significant contributions to the field of medical diagnostics, particularly in the area of muscular dystrophies. With a total of 2 patents to his name, Rouillon is recognized for his innovative approaches to diagnosing and monitoring these conditions.
Latest Patents
Rouillon's latest patents include groundbreaking methods for diagnosing and monitoring muscular dystrophies. One of his inventions relates to a method for prognosing, diagnosing, determining the risk, and monitoring the evolution of muscular dystrophy. This method also evaluates the efficacy of treatments for individuals affected by this condition. Another significant patent involves a method for diagnosing muscular dystrophy by detecting titin or its fragments in bodily fluids. These advancements are crucial for improving patient care and treatment outcomes.
Career Highlights
Jérémy Rouillon is currently associated with Genethon, a company dedicated to gene therapy and innovative treatments for genetic diseases. His work at Genethon has allowed him to focus on developing methods that enhance the understanding and management of muscular dystrophies. His contributions are vital in the ongoing research and development in this field.
Collaborations
Rouillon collaborates with esteemed colleagues such as Fedor Svinartchouk and Isabelle Richard. Their combined expertise fosters an environment of innovation and progress in the research of muscular dystrophies.
Conclusion
Jérémy Rouillon stands out as an influential inventor in the realm of medical diagnostics. His patents and work at Genethon significantly contribute to the understanding and treatment of muscular dystrophies. His innovative methods pave the way for improved patient outcomes and advancements in medical science.